/Investor DB

Nat Turner — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Relayrelaytx.comin𝕏NASDAQ: RLAYJan 2024

Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques.

AI & Machine LearningBiotechDeep TechCambridge, US

Donald A. Bergstrom(Executive Officer)inSanjiv K. Patel(Director, President and Chief Executive Officer)inSekar Kathiresan(Director)Douglas S. Ingram(Director)Mark Murcko(Director)Laura Shawver(Director)

Co-investorsCommonweal VenturesEcoR1 CapitalForesite CapitalNextech InvestSoftBank Vision FundCurie.Bio+2 more

Octavefindoctave.cominFeb 2024

Octave is a mental health practice platform that connects licensed therapists with patients seeking in-network mental health care.

Digital HealthHealthtechMental HealthSaaSSan Francisco, US

Sandeep Acharya(Founder, CEO)inDavid White(Executive Officer)in

BoardSaurabh Bhansali(Director)inEllie Wheeler(Director)Craig Cimini(Director)

Co-investorsFelicis VenturesGreycroftHealthier CapitalObvious VenturesCompany VenturesDeerfield Management Company+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.